EUVIMEDSkopri EUVIMED
Open access · CC BY-NC 3.0

Bone Marrow-Derived Macrophages Loaded with Boron Carbide Nanoparticles Targeting the Glioblastoma Microenvironment for Boron Neutron Capture Therapy

Anna Rudawska iD, Agnieszka Szczygieł iD, Katarzyna Węgierek-Ciura, Jagoda Mierzejewska, Dawid Kozień, Paulina Żeliszewska, Monika Chaszczewska-Markowska, Piotr Rusiniak iD, Katarzyna Wątor iD, Zbigniew Pędzich, Elżbieta Pajtasz-Piasecka, Bożena Szermer-Olearnik iD

International Journal of Nanomedicine · 2026

DOI: 10.2147/ijn.s604151 ↗

At a glance

Journal article in International Journal of Nanomedicine, 2026. Written by Anna Rudawska and 11 co-authors. Institution: Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, Poland. Major MEDLINE topics: Macrophages, Boron Neutron Capture Therapy, Glioblastoma, Boron Compounds. Cited 2 times so far (Crossref); 34 references. The full text is freely available (open access, CC BY-NC 3.0).

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Introduction

Boron neutron capture therapy (BNCT) is a targeted radiotherapy that represents a promising treatment for glioblastoma multiforme. BNCT efficacy depends on selective boron carriers capable of crossing the blood-brain barrier (BBB). Therefore, we propose an original strategy for boron delivery in BNCT, based on the cellular carriers. This study assessed the ability of bone marrow-derived macrophages (BMDMs) to accumulate boron carbide (B4C) nanoparticles, transport them across an in vitro BBB model toward glioblastoma cell-conditioned medium, and interact with tumor cells.

Methods

The uptake and accumulation of B4C nanoparticles by BMDMs in different polarization states (M0, M1, M2) were confirmed by holotomography and ICP-MS. The scratch assay assessed spontaneous migration of BMDMs loaded with B4C nanoparticles. The Transwell system was used to determine the ability of BMDMs with B4C to cross bEnd.3 brain endothelial cell monolayer, mimicking the BBB, toward GL-261 glioblastoma cell-conditioned medium rich in CCL2. Macrophage interactions with glioblastoma spheroids were investigated using the CellTiter-Glo 3D Cell Viability Assay and flow cytometry.

Results

All BMDM populations demonstrated the ability to accumulate B4C nanoparticles, with the significantly highest boron concentration detected in M1 macrophages (21.53 ± 1.64 mg/L per 106 cells). Moreover, M0, M1, and M2 macrophages loaded with B4C nanoparticles were capable of migrating through the brain endothelial cell monolayer, toward the glioblastoma cell-conditioned medium. BMDMs with nanoparticles did not affect the viability of glioblastoma spheroids after 6 days of co-culture, in contrast to macrophages without nanoparticles, which increased the survival of tumor cells. Importantly, CD206 expression was not increased in M1 macrophages after contact with spheroids, and was lower in M2 macrophages loaded with B4C nanoparticles compared to control M2 macrophages.

Conclusion

BMDMs are promising carriers of B4C nanoparticles for BNCT due to their ability to cross the in vitro BBB model toward the glioblastoma microenvironment.

Subjects

MeSH terms (MEDLINE)

MacrophagesBoron Neutron Capture TherapyGlioblastomaBoron CompoundsBrain NeoplasmsNanoparticlesAnimalsCell Line, TumorMiceTumor MicroenvironmentBlood-Brain BarrierHumansCell SurvivalCell Movement

Author keywords

blood-brain barrierboron carbide nanoparticlesboron neutron capture therapycellular carriersglioblastoma multiformemacrophages

Substances

Boron Compounds

Authors and institutions

  • Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, Poland.
  • Department of Materials Science and Ceramics, AGH University of Krakow, Krakow, Poland.
  • Jerzy Haber Institute of Catalysis and Surface Chemistry, Polish Academy of Sciences, Krakow, Poland.
  • Department of Geology, Geophysics and Environmental Protection, AGH University of Krakow, Krakow, Poland.

ORCID profiles: Anna Rudawska, Agnieszka Szczygieł, Piotr Rusiniak, Katarzyna Wątor, Bożena Szermer-Olearnik

Cite

APA

Rudawska, A., Szczygieł, A., Węgierek-Ciura, K., Mierzejewska, J., Kozień, D., Żeliszewska, P., Chaszczewska-Markowska, M., Rusiniak, P., Wątor, K., Pędzich, Z., Pajtasz-Piasecka, E., & Szermer-Olearnik, B. (2026). Bone Marrow-Derived Macrophages Loaded with Boron Carbide Nanoparticles Targeting the Glioblastoma Microenvironment for Boron Neutron Capture Therapy. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s604151

Vancouver

Rudawska A, Szczygieł A, Węgierek-Ciura K, Mierzejewska J, Kozień D, Żeliszewska P, et al. Bone Marrow-Derived Macrophages Loaded with Boron Carbide Nanoparticles Targeting the Glioblastoma Microenvironment for Boron Neutron Capture Therapy. International Journal of Nanomedicine. 2026. doi:10.2147/ijn.s604151

BibTeX
@article{Rudawska2026,
  author = {Rudawska, Anna and Szczygieł, Agnieszka and Węgierek-Ciura, Katarzyna and Mierzejewska, Jagoda and Kozień, Dawid and Żeliszewska, Paulina and Chaszczewska-Markowska, Monika and Rusiniak, Piotr and Wątor, Katarzyna and Pędzich, Zbigniew and Pajtasz-Piasecka, Elżbieta and Szermer-Olearnik, Bożena},
  title = {Bone Marrow-Derived Macrophages Loaded with Boron Carbide Nanoparticles Targeting the Glioblastoma Microenvironment for Boron Neutron Capture Therapy},
  journal = {International Journal of Nanomedicine},
  year = {2026},
  doi = {10.2147/ijn.s604151}
}
Start for free →